Category Archives: Drug Recall

Recall lawyer on MDLs and class actions: What’s the best fit?

A recalled metal hip implant is the subject of a mass tort, but a recalled can of peanut butter might lead to a class action lawsuit. Likewise, claims over a defective camera are treated as a class action, while injuries caused by dangerous hormone therapy medication are dealt with using a mass tort vehicle known…

Recall lawyers to tackle drug and device cases at JPML

Dangerous drugs and medical devices including testosterone therapy and metal hips will be on the agenda at this week’s meeting of the Judicial Panel on Multidistrict Litigation, or JPML. The panel of seven federal judges will meet at 9:30 Thursday morning in Chicago to hear arguments about dozens of mass tort cases, including MDL 2545,…

Hip implant article explains details of medical device litigation

The complex world of medical device litigation, including lawsuits over failed metal-on-metal hip implants, is described in an article published by Attorney Alex Davis of Jones Ward PLC. The widespread failure of metal-on-metal hip implants represents one of the worst product liability disasters in decades, the article says. Jones Ward PLC represents consumers injured by…

Sales of Leukemia Drug Iclusig Stopped After Severe Side Effects Found

Sales of a promising leukemia drug, Iclusig, are being suspended because of “the risk of life-threatening blood clots and severe narrowing of blood vessels,” the Food and Drug Administration says. The drug, also known as ponatinib, has been linked to heart attacks and strokes, blindness and loss of blood flow in the extremities serious enough…

Larry Jones featured in Today Show probe on generic drugs

Attorney Larry Jones, one of the founding partners of Jones Ward PLC, spoke to reporters from the Today Show for a segment that aired this morning on the dangers of generic prescription drugs. The segment, aired on national television, told the story of Viola Purcell, who took a generic form of metoclopramide, a drug normally…

FDA Suspends Sales of New Leukemia Treatment

The Food and Drug Administration has suspended the sales of a new leukemia treatment, Iclusig, effective immediately. The drug is manufactured by Ariad Pharmaceuticals and is intended to treat chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia. The FDA says the drug creates “the risk of life-threatening blood clots and severe narrowing of…

Hospira Recalls Marcaine Lot Due to Reports of Rust Particulates

Hospira, Inc. announced Friday that it issued nationwide recall for one lot of 0.25% Marcaine. Hospira confirmed a customer report of visible particles and discoloration of one dose of Marcaine, identified it as iron oxide– more commonly known as rust. At least one of the particles was 3 mm in diameter. Marcaine, whose active ingredient…

Drug makers pay big money to influence FDA rules, report shows

It’s no secret that Big Pharma spends big money to influence government decisions on safety and health issues. But the latest revelation about industry efforts to sway important decisions on prescription drugs is nonetheless disturbing. In a story published in its Sunday edition, The Washington Post reports that some companies paid as much as $25,000…

Government Shutdown Impacts Food Safety, Epidemiology

The government shutdown that began yesterday and stopped numerous federal activities has also impacted the FDA, CDC, and the USDA. According to Carla Gillespie at the Food Poisoning Bulletin, approximately 45% of FDA staff have been furloughed. That is a lower rate than at the Department of Health and Human Services, which oversees both the…

Compounding Pharmacies May be Subject to More Oversight

According to a new bill under consideration in the United States Senate, compounding pharmacies would be subject to increased FDA oversight similar to that of drug makers. The bill comes in response to the notorious meningitis outbreak from the New England Compounding Center last year that killed 64 people. Senator Tom Harkin sponsored the bill…